vs
Neptune Insurance Holdings Inc.（NP）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Neptune Insurance Holdings Inc.的2.0倍（$75.5M vs $37.8M），Neptune Insurance Holdings Inc.同比增速更快（28.8% vs 27.7%）
海王星保险控股有限公司是一家专业保险控股企业，主要经营财产及意外伤害保险业务，核心产品覆盖美国市场的住宅与商业洪水保险，服务个人消费者及中小型商业客户，依托数据分析实现精准定价和高效风险管理。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NP vs PBYI — 直观对比
营收规模更大
PBYI
是对方的2.0倍
$37.8M
营收增速更快
NP
高出1.0%
27.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.8M | $75.5M |
| 净利润 | $50.0K | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 0.1% | — |
| 营收同比 | 28.8% | 27.7% |
| 净利润同比 | 0.0% | — |
| 每股收益（稀释后） | $0.05 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPPBYI
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | $75.5M | ||
| Q3 25 | $44.4M | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $33.8M | $80.5M | ||
| Q2 24 | — | $47.1M |
净利润NPPBYI
| Q1 26 | $50.0K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $11.5M | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $12.1M | $20.3M | ||
| Q2 24 | — | $-4.5M |
毛利率NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 22.7% | ||
| Q3 25 | 46.7% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 58.6% | 27.4% | ||
| Q2 24 | — | -4.6% |
净利率NPPBYI
| Q1 26 | 0.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.9% | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 35.8% | 25.2% | ||
| Q2 24 | — | -9.6% |
每股收益（稀释后）NPPBYI
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.06 | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.06 | $0.41 | ||
| Q2 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | — | $130.3M |
| 总资产 | — | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | $12.2M | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | $247.6M | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $130.3M | ||
| Q3 25 | $-509.5M | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $-374.3M | $71.1M | ||
| Q2 24 | — | $48.5M |
总资产NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $216.3M | ||
| Q3 25 | $89.6M | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M |
负债/权益比NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | $38.9M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率NPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
